A novel combination treatment for breast cancer cells involving BAPTA-AM and proteasome inhibitor bortezomibAzmi Yerlikaya(Dumlupinar University), Bircan Savran(Dumlupinar University)Oncology LettersMay 17, 201610.3892/ol.2016.4597Cited by 22SaveCiteExport RISWatch citationsRelated PapersAn investigation of the mechanisms underlying the proteasome inhibitor bortezomib resistance in PC3 prostate cancer cell line|Cytotechnology|2019|13